წყაროები
ძირითადი სტატიები
World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Sep 2015 [internet publication].სრული ტექსტი
US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Feb 2024 [internet publication].სრული ტექსტი
World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO Press; 2007 [internet publication].სრული ტექსტი
გამოყენებული სტატიები
1. World Health Organization. HIV/AIDS: online QA. Nov 2022 [internet publication].სრული ტექსტი
2. Worobey M. The origins and diversifications of HIV. In: Volberding P, Sande M, Lange J, et al., eds. Global HIV/AIDS medicine. Philadelphia, PA: Elsevier; 2008.
3. Wilson D, Naidoo S, Bekker LG, et al. Handbook of HIV medicine. South Africa: Oxford University Press; 2002.
4. Robertson DL, Anderson JP, Bradac JL, et al. HIV-1 nomenclature proposal. Science. 2000 Apr 7;288(5463):55-6. აბსტრაქტი
5. Hemelaar J, Elangovan R, Yun J, et al. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2018 Nov 30. pii: S1473-3099(18)30647-9. აბსტრაქტი
6. Yamaguchi J, McArthur C, Vallari A, et al. Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L. J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):319-22. აბსტრაქტი
7. Wymant C, Bezemer D, Blanquart F, et al. A highly virulent variant of HIV-1 circulating in the Netherlands. Science. 2022 Feb 4;375(6580):540-5.სრული ტექსტი აბსტრაქტი
8. Gottlieb GS, Raugi DN, Smith RA. 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2. Lancet HIV. 2018 Jul;5(7):e390-9. აბსტრაქტი
9. Fidler S, Fox J. Primary HIV infection: a medical and public health emergency requiring rapid specialist management. Clin Med (Lond). 2016 Apr;16(2):180-3.სრული ტექსტი აბსტრაქტი
10. Joint United Nations Programme on HIV/AIDS. In danger: UNAIDS global AIDS update 2022. 2022 [internet publication].სრული ტექსტი
11. GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019 Dec;6(12):e831-9.სრული ტექსტი აბსტრაქტი
12. Li Z, Purcell DW, Sansom SL, et al. Vital signs: HIV transmission along the continuum of care - United States, 2016. MMWR Morb Mortal Wkly Rep. 2019 Mar 22;68(11):267-72.სრული ტექსტი აბსტრაქტი
13. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2021 – 2020 data. Stockholm: ECDC; 2021.სრული ტექსტი
14. UK Health Security Agency. HIV testing, PrEP, new HIV diagnoses, and care outcomes for people accessing HIV services: 2023 report. Oct 2023 [internet publication].სრული ტექსტი
15. Centers for Disease Control and Prevention. Estimated annual number of HIV infections - United States, 1981-2019. MMWR Morb Mortal Wkly. 2021 Jun 4:70(22);801-6.სრული ტექსტი
16. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2017–2021. May 2023 [internet publication].სრული ტექსტი
17. Dailey AF, Gant Z, Hu X, et al. Association between social vulnerability and rates of HIV diagnoses among black adults, by selected characteristics and region of residence - United States, 2018. MMWR Morb Mortal Wkly Rep 2022;71:167-70.სრული ტექსტი აბსტრაქტი
18. Lee K, Trujillo L, Olansky E, et al. Factors associated with use of HIV prevention and health care among transgender women - seven urban areas, 2019-2020. MMWR Morb Mortal Wkly Rep. 2022 May 20;71(20):673-9.სრული ტექსტი აბსტრაქტი
19. Nyamweya S, Hegedus A, Jaye A, et al. Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis. Rev Med Virol. 2013 Jul;23(4):221-40. აბსტრაქტი
20. Pope M, Hause AT. Transmission, acute HIV-1 infection and the quest to prevent infection. Nat Med. 2003 Jul;9(7):847-52. აბსტრაქტი
21. Gupta R, Hill A, Sawyer AW, et al. Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials. Clin Infect Dis. 2008 Sep 1;47(5):712-22.სრული ტექსტი აბსტრაქტი
22. Morris L, Cilliers T. Viral structure, replication, tropism, pathogenesis and natural history. In: Abdool Karim SS, Abdool Karim Q, eds. HIV/AIDS in South Africa. Cambridge University Press; 2005:79-89.
23. Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Def Syndr Hum Retrovirol. 1995 Oct 1;10(2):175-6. აბსტრაქტი
24. Artenie A, Stone J, Fraser H, et al. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023 Mar 27;S2468-1253(23)00018-3.სრული ტექსტი აბსტრაქტი
25. Farhadian N, Karami Matin B, Farnia V, et al. The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis. Subst Abuse Treat Prev Policy. 2022 Feb 10;17(1):11.სრული ტექსტი აბსტრაქტი
26. Arum C, Fraser H, Artenie AA, et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021 May;6(5):e309-23.სრული ტექსტი აბსტრაქტი
27. Malekinejad M, Barker EK, Merai R, et al. Risk of HIV acquisition among men who have sex with men infected with bacterial sexually transmitted infections: a systematic review and meta-analysis. Sex Transm Dis. 2021 Oct 1;48(10):e138-48.სრული ტექსტი აბსტრაქტი
28. Varghese B, Maher JE, Peterman TA, et al. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002 Jan;29(1):38-43. აბსტრაქტი
29. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ. 1992 Mar 28;304(6830):809-13.სრული ტექსტი აბსტრაქტი
30. Bell DM. Occupational risk of human immunodeficiency virus infection in health care workers: an overview. Am J Med. 1997 May 19;102(5B):9-15. აბსტრაქტი
31. Cooper ER, Charurat M, Mofenson L, et al; Women and Infants' Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94. აბსტრაქტი
32. Polis CB, Curtis KM, Hannaford PC, et al. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS. 2016 Nov 13;30(17):2665-83.სრული ტექსტი აბსტრაქტი
33. Tepper NK, Curtis KM, Cox S, et al. Update to U.S. medical eligibility criteria for contraceptive use, 2016: updated recommendations for the use of contraception among women at high risk for HIV infection. MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):405-10.სრული ტექსტი აბსტრაქტი
34. World Health Organization. Contraceptive eligibility for women at high risk of HIV: guidance statement - recommendations on contraceptive methods used by women at high risk of HIV. 2019 [internet publication].სრული ტექსტი
35. Looker KJ, Elmes JAR, Gottlieb SL, et al. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect Dis. 2017 Dec;17(12):1303-16.სრული ტექსტი აბსტრაქტი
36. Looker KJ, Welton NJ, Sabin KM, et al. Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data. Lancet Infect Dis. 2020 Feb;20(2):240-9.სრული ტექსტი აბსტრაქტი
37. Marfatia YS, Pandya I, Mehta K. Condoms: Past, present, and future. Indian J Sex Transm Dis AIDS. 2015 Jul-Dec;36(2):133-9.სრული ტექსტი აბსტრაქტი
38. Hanum N, Cambiano V, Sewell J, et al. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Lancet Public Health. 2020 Sep;5(9):e501-11.სრული ტექსტი აბსტრაქტი
39. Finlayson T, Cha S, Xia M, et al; National HIV Behavioral Surveillance Study Group. Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men - 20 urban areas, 2014 and 2017. MMWR Morb Mortal Wkly Rep. 2019 Jul 12;68(27):597-603.სრული ტექსტი აბსტრაქტი
40. Riddell J 4th, Amico KR, Mayer KH. HIV preexposure prophylaxis: a review. JAMA. 2018 Mar 27;319(12):1261-8. აბსტრაქტი
41. O Murchu E, Marshall L, Teljeur C, et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022 May 11;12(5):e048478.სრული ტექსტი აბსტრაქტი
42. Jourdain H, de Gage SB, Desplas D, et al. Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study. Lancet Public Health. 2022 Jun;7(6):e529-36.სრული ტექსტი აბსტრაქტი
43. Sullivan AK, Saunders J, Desai M, et al. HIV pre-exposure prophylaxis and its implementation in the PrEP impact trial in England: a pragmatic health technology assessment. Lancet HIV. 2023 Dec;10(12):e790-806.სრული ტექსტი აბსტრაქტი
44. Delaugerre C, Rodriguez C, Capitant C, et al. Drug resistance among patients who acquired HIV infection in a preexposure prophylaxis trial. AIDS. 2018;32(16):2353-61. აბსტრაქტი
45. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Sep 2015 [internet publication].სრული ტექსტი
46. Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States - 2021 update: a clinical practice guideline. Dec 2021 [internet publication].სრული ტექსტი
47. American College of Obstetricians and Gynecologists. Practice advisory to committee opinion no. 595: preexposure prophylaxis for the prevention of human immunodeficiency virus. Jun 2022 [internet publication].სრული ტექსტი
48. US Preventive Services Task Force. Recommendation: prevention of acquisition of HIV: preexposure prophylaxis. Aug 2023 [internet publication].სრული ტექსტი
49. Holt M, Lea T, Mao L, et al. Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013-17. Lancet HIV. 2018 Aug;5(8):e448-56. აბსტრაქტი
50. Hart TA, Noor SW, Berlin GW, et al. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men. Sex Transm Infect. 2023 May;99(3):167-72.სრული ტექსტი აბსტრაქტი
51. Cohen SE, Sachdev D, Lee SA, et al. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV. 2018 Nov 29 [Epub ahead of print]. აბსტრაქტი
52. Tumarkin E, Siedner MJ, Bogoch II. The BMJ 10-minute consultation: HIV pre-exposure prophylaxis (PrEP). BMJ. 2019 Jan 17;364:k4681.
53. US Food and Drug Administration. FDA approves first injectable treatment for HIV pre-exposure prevention. Dec 2021 [internet publication].სრული ტექსტი
54. Marshall BDL, Goedel WC, King MRF, et al. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. Lancet HIV. 2018 Sep;5(9):e498-505.სრული ტექსტი აბსტრაქტი
55. Landovitz RJ, Hanscom BS, Clement ME, et al. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV. 2023 Dec;10(12):e767-78.სრული ტექსტი აბსტრაქტი
56. World Health Organization. Guidelines on long-acting injectable cabotegravir for HIV prevention. Jul 2022 [internet publication].სრული ტექსტი
57. Antoni G, Tremblay C, Delaugerre C, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020 Feb;7(2):e113-20. აბსტრაქტი
58. Lattré T, Van Holder C. Revisiting the functional severity scale of the Boston carpal tunnel questionnaire, a comment concerning the use of digital communication technology. Muscle Nerve. 2021 Jun;63(6):E57-8.სრული ტექსტი აბსტრაქტი
59. Musekiwa A, Fernando NB, Abariga SA. Effectiveness of vaginal microbicides in preventing HIV transmission. Trop Med Int Health. 2020 Jul;25(7):790-802.სრული ტექსტი აბსტრაქტი
60. Nel A, van Niekerk N, Kapiga S, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016 Dec 1;375(22):2133-43.სრული ტექსტი აბსტრაქტი
61. World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Jul 2021 [internet publication].სრული ტექსტი
62. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010 Sep 3;329(5996):1168-74.სრული ტექსტი აბსტრაქტი
63. Anglemyer A, Rutherford GW, Horvath T, et al. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009153.სრული ტექსტი აბსტრაქტი
64. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493-505.სრული ტექსტი აბსტრაქტი
65. Rodger AJ, Cambiano V, Bruun T, et al; PARTNER Study Group. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016 Jul 12;316(2):171-81.სრული ტექსტი აბსტრაქტი
66. Bavinton BR, Pinto AN, Phanuphak N, et al; Opposites Attract Study Group. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018 Aug;5(8):e438-47. აბსტრაქტი
67. PARTNER Study Group. HIV transmission risk through condomless sex in gay couples with suppressive ART: the PARTNER2 Study extended results in gay men. 2018 [internet publication].სრული ტექსტი
68. Rodger AJ, Cambiano V, Bruun T, et al; PARTNER Study Group. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019 Jun 15;393(10189):2428-38.სრული ტექსტი აბსტრაქტი
69. LeMessurier J, Traversy G, Varsaneux O, et al. Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review. CMAJ. 2018 Nov 19;190(46):E1350-60.სრული ტექსტი აბსტრაქტი
70. Broyles LN, Luo R, Boeras D, et al. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review. Lancet. 2023 Aug 5;402(10400):464-71.სრული ტექსტი აბსტრაქტი
71. US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Feb 2024 [internet publication].სრული ტექსტი
72. Sharma SC, Raison N, Khan S, et al. Male circumcision for the prevention of human immunodeficiency virus (HIV) acquisition: a meta-analysis. BJU Int. 2018 Apr;121(4):515-26.სრული ტექსტი აბსტრაქტი
73. Yuan T, Fitzpatrick T, Ko NY, et al. Circumcision to prevent HIV and other sexually transmitted infections in men who have sex with men: a systematic review and meta-analysis of global data. Lancet Glob Health. 2019 Apr;7(4):e436-47.სრული ტექსტი აბსტრაქტი
74. Farley TM, Samuelson J, Grabowski MK, et al. Impact of male circumcision on risk of HIV infection in men in a changing epidemic context - systematic review and meta-analysis. J Int AIDS Soc. 2020 Jun;23(6):e25490.სრული ტექსტი აბსტრაქტი
75. Delany-Moretlwe S, Gray G, Kagee A, et al. AIDS prevention in South Africa. South Afr J HIV Med. 2006;23:13-7.
76. Rubens M, Ramamoorthy V, Saxena A, et al. HIV vaccine: recent advances, current roadblocks, and future directions. J Immunol Res. 2015;2015:560347.სრული ტექსტი აბსტრაქტი
77. Leal L, Lucero C, Gatell JM, et al. New challenges in therapeutic vaccines against HIV infection. Expert Rev Vaccines. 2017 Jun;16(6):587-600. აბსტრაქტი
78. Baden LR, Stieh DJ, Sarnecki M, et al. Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study. Lancet HIV. 2020 Oct;7(10):e688-98.სრული ტექსტი აბსტრაქტი
79. Gbadamosi SO, Trepka MJ, Dawit R, et al. A systematic review and meta-analysis to estimate the time from HIV infection to diagnosis for people with HIV. AIDS Rev. 2022 Mar 1;24(1):32-40.სრული ტექსტი აბსტრაქტი
80. Centers for Disease Control and Prevention. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Jun 2014 [internet publication].სრული ტექსტი
81. Centers for Disease Control and Prevention. Revised surveillance case definition for HIV infection: United States, 2014. MMWR Recomm Rep. 2014;63(RR-03):1-10.სრული ტექსტი აბსტრაქტი
82. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO Press; 2007 [internet publication].სრული ტექსტი
83. World Health Organization, UNAIDS. WHO, UNAIDS statement on HIV testing services: new opportunities and ongoing challenges. Aug 2017 [internet publication].სრული ტექსტი
84. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med 2018;56(12):2015-38. აბსტრაქტი
85. World Health Organization. WHO recommends HIV self-testing – evidence update and considerations for success. Nov 2019 [internet publication].სრული ტექსტი
86. World Health Organization. WHO recommends optimizing HIV testing services. Jul 2023 [internet publication].სრული ტექსტი
87. World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Jul 2017 [internet publication].სრული ტექსტი
88. World Health Organization. HIV drug resistance report 2021. Nov 2021 [internet publication].სრული ტექსტი
89. Shepher J, Quinn T. Laboratory testing for HIV infection. In: Volberding P, Sande M, Lange J, et al., eds. Global HIV/AIDS medicine. Philadelphia, PA: Elsevier; 2008:101-7.
90. Deeks SG, Gange SJ, Kitahata MM, et al. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009 Nov 15;49(10):1582-90.სრული ტექსტი აბსტრაქტი
91. Aves T, Tambe J, Siemieniuk RA, et al. Antiretroviral resistance testing in HIV-positive people. Cochrane Database Syst Rev. 2018 Nov 9;(11):CD006495.სრული ტექსტი აბსტრაქტი
92. Julian T, Rekatsina M, Shafique F, et al. Human immunodeficiency virus-related peripheral neuropathy: a systematic review and meta-analysis. Eur J Neurol. 2021 Apr;28(4):1420-31. აბსტრაქტი
93. Ochodo EA, Olwanda EE, Deeks JJ, et al. Point‐of‐care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities. Cochrane Database Syst Rev. 2022 Mar 10;3(3):CD013208.სრული ტექსტი აბსტრაქტი
94. World Health Organization. WHO manual for HIV drug resistance testing using dried blood spot specimens. Oct 2020 [internet publication].სრული ტექსტი
95. Marchionatti A, Parisi MM. Anemia and thrombocytopenia in people living with HIV/AIDS: a narrative literature review. Int Health. 2021 Feb 24;13(2):98-109.სრული ტექსტი აბსტრაქტი
96. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17;quiz CE1-4.სრული ტექსტი აბსტრაქტი
97. DiNenno EA, Prejean J, Irwin K, et al. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017 Aug 11;66(31):830-2.სრული ტექსტი აბსტრაქტი
98. Pitasi MA, Oraka E, Clark H, et al. HIV testing among transgender women and men - 27 states and Guam, 2014-2015. MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):883-7.სრული ტექსტი აბსტრაქტი
99. Pitasi MA, Delaney KP, Oraka E, et al. Interval since last HIV test for men and women with recent risk for HIV infection - United States, 2006-2016. MMWR Morb Mortal Wkly Rep. 2018 Jun 22;67(24):677-81.სრული ტექსტი აბსტრაქტი
100. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for HIV infection: US Preventive Services Task Force recommendation statement. JAMA. 2019 Jun 18;321(23):2326-36.სრული ტექსტი აბსტრაქტი
101. The Voluntary HIV Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania and Trinidad: a randomised trial. Lancet. 2000 Jul 8;356(9224):103-12. აბსტრაქტი
102. Smith R, Villanueva G, Probyn K, et al. Accuracy of measures for antiretroviral adherence in people living with HIV. Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD013080.სრული ტექსტი აბსტრაქტი
103. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Sep 2023 [internet publication].სრული ტექსტი
104. Grobler L, Siegfried N, Visser ME, et al. Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004536.სრული ტექსტი აბსტრაქტი
105. Olsen MF, Abdissa A, Kaestel P, et al. Effects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in Ethiopia. BMJ. 2014 May 15;348:g3187.სრული ტექსტი აბსტრაქტი
106. Visser ME, Durao S, Sinclair D, et al. Micronutrient supplementation in adults with HIV infection. Cochrane Database Syst Rev. 2017 May 18;(5):CD003650.სრული ტექსტი აბსტრაქტი
107. Teixeira NDSCCA, Pereira BM, Oliveira IKF, et al. Effect of vitamin D3 supplementation on HIV-infected adults: a systematic review. Nutr Hosp. 2019 Oct 17;36(5):1205-12.სრული ტექსტი აბსტრაქტი
108. Muzembo BA, Ngatu NR, Januka K, et al. Selenium supplementation in HIV-infected individuals: A systematic review of randomized controlled trials. Clin Nutr ESPEN. 2019 Dec;34:1-7.სრული ტექსტი აბსტრაქტი
109. Morvaridzadeh M, Sepidarkish M, Yavari M, et al. The effects of omega-3 fatty acid supplementation on inflammatory factors in HIV-infected patients: a systematic review and meta-analysis of randomized clinical trials. Cytokine. 2020 Dec;136:155298.სრული ტექსტი აბსტრაქტი
110. US Department of Health and Human Services. HIV and immunizations. Aug 2021 [internet publication].სრული ტექსტი
111. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015 Aug 27;373(9):795-807.სრული ტექსტი აბსტრაქტი
112. Mateo-Urdiales A, Johnson S, Smith R, et al. Rapid initiation of antiretroviral therapy for people living with HIV. Cochrane Database Syst Rev. 2019 Jun 17;(6):CD012962.სრული ტექსტი აბსტრაქტი
113. Feng Q, Zhou A, Zou H, et al. Quadruple versus triple combination antiretroviral therapies for treatment naive people with HIV: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019 Jul 8;366:l4179.სრული ტექსტი აბსტრაქტი
114. National Institute for Health Research. NIHR Signal: Four-drug treatment for HIV offers no benefit over standard three-drug treatment. Sep 2019 [internet publication].სრული ტექსტი
115. Cahn P, Madero JS, Arribas J, et al. Non-inferior efficacy of dolutegravir (DTG) plus lamivudine (3TC) versus DTG plus tenofovir/emtricitabine (TDF/FTC) fixed-dose combination in antiretroviral treatment-naive adults with HIV-1 infection - 48-week results from the GEMINI studies. Paper presented at: 22nd International AIDS Conference (AIDS 2018). 2018. Amsterdam, Netherlands.სრული ტექსტი
116. Cento V, Perno CF. Two-drug regimens with dolutegravir plus rilpivirine or lamivudine in HIV-1 treatment-naïve, virologically-suppressed patients: latest evidence from the literature on their efficacy and safety. J Glob Antimicrob Resist. 2020 Mar;20:228-37.სრული ტექსტი აბსტრაქტი
117. World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. Dec 2018 [internet publication].სრული ტექსტი
118. Wang H, Lu X, Yang X, et al. The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: meta-analysis. Medicine (Baltimore). 2016 Oct;95(41):e5146.სრული ტექსტი აბსტრაქტი
119. Tao X, Lu Y, Zhou Y, et al. Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: a meta-analysis of randomized controlled trials. Int J Infect Dis. 2020 Apr;93:108-17.სრული ტექსტი აბსტრაქტი
120. World Health Organization. Guidelines on the public health response to pretreatment HIV drug resistance. Jul 2017 [internet publication].სრული ტექსტი
121. Lederman MM, Calabrese L, Funderburg NT, et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis. 2011 Oct 15;204(8):1217-26.სრული ტექსტი აბსტრაქტი
122. El Bouzidi K, Jose S, Phillips AN, et al. First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines. AIDS. 2020 Oct 1;34(12):1823-31.სრული ტექსტი აბსტრაქტი
123. Lindegren ML, Kennedy CE, Bain-Brickley D, et al. Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD010119.სრული ტექსტი აბსტრაქტი
124. Islam FM, Wu J, Jansson J, et al. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012 Sep;13(8):453-68. აბსტრაქტი
125. Segarra-Newnham M, Soffler SL. Osteoporosis and vitamin D deficiency in HIV-positive patients. J Pharm Technol. 2011;27:251-7.
126. National Institute for Health and Care Excellence. Cabotegravir with rilpivirine for treating HIV-1. Jan 2022 [internet publication].სრული ტექსტი
127. Rizzardini G, Overton ET, Orkin C, et al. Long-acting injectable cabotegravir + rilpivirine for HIV maintenance therapy: week 48 pooled analysis of phase 3 ATLAS and FLAIR trials. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):498-506.სრული ტექსტი აბსტრაქტი
128. Chahine EB, Durham SH. Ibalizumab: the first monoclonal antibody for the treatment of HIV-1 infection. Ann Pharmacother. 2021 Feb;55(2):230-9. აბსტრაქტი
129. Emu B, Fessel J, Schrader S, et al. Phase 3 study of ibalizumab for multidrug-resistant HIV-1. N Engl J Med. 2018 Aug 16;379(7):645-54.სრული ტექსტი აბსტრაქტი
130. Gilead Sciences. Study to evaluate the safety and efficacy of lenacapavir in combination with an optimized background regimen in heavily treatment experienced participants living with HIV-1 infection with multidrug resistance (CAPELLA). Feb 2021 [internet publication].სრული ტექსტი
131. Gupta SK, Berhe M, Crofoot G, et al. Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial. Lancet HIV. 2023 Jan;10(1):e15-23. აბსტრაქტი
132. Ogbuagu O, Segal-Maurer S, Ratanasuwan W, et al. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial. Lancet HIV. 2023 Aug;10(8):e497-e505. აბსტრაქტი
133. Lataillade M, Lalezari JP, Kozal M, et al. Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study. Lancet HIV. 2020 Nov;7(11):e740-51.სრული ტექსტი აბსტრაქტი
134. Li L, Tian JH, Yang K, et al. Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection. Cochrane Database Syst Rev. 2014 Jul 26;(7):CD008439.სრული ტექსტი აბსტრაქტი
135. Lalezari JP, Latiff GH, Brinson C, et al. Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial. Lancet HIV. 2015 Oct;2(10):e427-37. აბსტრაქტი
136. Murgatroyd C, Pirrie L, Tran F, et al. Structure-activity relationships of the human immunodeficiency virus type 1 maturation inhibitor PF-46396. J Virol. 2016 Aug 26;90(18):8181-97.სრული ტექსტი აბსტრაქტი
137. US National Library of Medicine. Study to evaluate the safety of a gene and cell therapy product in participants with HIV that is well-controlled on antiretroviral therapy. Sep 2020 [internet publication].სრული ტექსტი
138. Perera Molligoda Arachchige AS. NK cell-based therapies for HIV infection: investigating current advances and future possibilities. J Leukoc Biol. 2022 Apr;111(4):921-31. აბსტრაქტი
139. Trickey A, Sabin CA, Burkholder G, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023 Mar 20;S2352-3018(23)00028-0.სრული ტექსტი აბსტრაქტი
140. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003 May 12;163(9):1009-21.სრული ტექსტი აბსტრაქტი
141. O'Connor J, Smith C, Lampe FC, et al. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study. Lancet HIV. 2017 Jul;4(7):e295-302.სრული ტექსტი აბსტრაქტი
142. Nance RM, Delaney JAC, Simoni JM, et al. HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: a cohort study. Ann Intern Med. 2018;169(6):376-84.სრული ტექსტი აბსტრაქტი
143. Trickey A, McGinnis K, Gill MJ, et al. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. Lancet HIV. 2024 Mar;11(3):e176-85.სრული ტექსტი აბსტრაქტი
144. Bosh KA, Johnson AS, Hernandez AL, et al. Vital signs: deaths among persons with diagnosed HIV infection, United States, 2010-2018. MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1717-24.სრული ტექსტი აბსტრაქტი
145. Teeraananchai S, Kerr SJ, Amin J, et al. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017 Apr;18(4):256-66. აბსტრაქტი
146. Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017 Aug;4(8):e349-56.სრული ტექსტი აბსტრაქტი
147. Engels EA, Yanik EL, Wheeler W, et al. Cancer-attributable mortality among people with treated human immunodeficiency virus infection in North America. Clin Infect Dis. 2017 Aug 15;65(4):636-43.სრული ტექსტი
148. Ghislain MR, Mushebenge GA, Magula N. Cause of hospitalization and death in the antiretroviral era in Sub-Saharan Africa published 2008-2018: a systematic review. Medicine (Baltimore). 2021 Oct 29;100(43):e27342.სრული ტექსტი აბსტრაქტი
149. Gupta RK, Peppa D, Hill AL, et al. Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report. Lancet HIV. 2020 May;7(5):e340-7.სრული ტექსტი აბსტრაქტი
150. World Health Organization. First case of HIV cure in a woman after stem cell transplantation reported at CROI-2022. 2022 Mar 24 [internet publication].სრული ტექსტი
151. Mandalia S, Westrop SJ, Beck EJ, et al. Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988-2010. PLoS One. 2012;7(2):e29844.სრული ტექსტი აბსტრაქტი
152. Lawn SD, Wilkinson RJ, Lipman MC, et al. Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Resp Crit Care Med. 2008 Apr 1;177(7):680-5. აბსტრაქტი
153. Shah ASV, Stelzle D, Lee KK, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV. Circulation. 2018;138(11):1100-12.სრული ტექსტი აბსტრაქტი
154. Losina E, Hyle EP, Borre ED, et al. Projecting 10-yr, 20-yr and lifetime risks of cardiovascular disease in persons living with HIV in the US. Clin Infect Dis. 2017 Oct 15;65(8):1266-71. აბსტრაქტი
155. Beckman JA, Duncan MS, Alcorn CW, et al. Association of human immunodeficiency virus infection and risk of peripheral artery disease. Circulation. 2018 Jul 17;138(3):255-65.სრული ტექსტი აბსტრაქტი
156. Ryom L, Lundgren JD, El-Sadr W, et al. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. Lancet HIV. 2018 Jun;5(6):e291-300. აბსტრაქტი
157. Neesgaard B, Greenberg L, Miró JM, et al. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium. Lancet HIV. 2022 Jul;9(7):e474-85. აბსტრაქტი
158. Osibogun O, Ogunmoroti O, Michos ED, et al. HIV/HCV coinfection and the risk of cardiovascular disease: a meta-analysis. J Viral Hepat. 2017 Nov;24(11):998-1004. აბსტრაქტი
159. Rao SG, Galaviz KI, Gay HC, et al. Factors associated with excess myocardial infarction risk in HIV-infected adults: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):224-30.სრული ტექსტი აბსტრაქტი
160. Feinstein MJ, Hsue PY, Benjamin LA, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association. Circulation. 2019 Jul 9;140(2):e98-124.სრული ტექსტი აბსტრაქტი
161. Howard JFB, Rokx C, Smit C, et al. Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study. Lancet HIV. 2019 Mar;6(3):e173-81. აბსტრაქტი
162. Abraham AG, Althoff KN, Jing Y, et al. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015 Mar 15;60(6):941-9.სრული ტექსტი აბსტრაქტი
163. Adnani H, Agrawal N, Khatri A, et al. Impact of antiretroviral therapy on kidney fisease in HIV infected individuals - a qualitative systematic review. J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221089194.სრული ტექსტი აბსტრაქტი
164. Hileman CO, Eckard AR, McComsey GA. Bone loss in HIV: a contemporary review. Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):446-51. აბსტრაქტი
165. Goh SSL, Lai PSM, Tan ATB, et al. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors. Osteoporos Int. 2018 Mar;29(3):595-613.სრული ტექსტი აბსტრაქტი
166. Pramukti I, Lindayani L, Chen YC, et al. Bone fracture among people living with HIV: a systematic review and meta-regression of prevalence, incidence, and risk factors. PLoS One. 2020;15(6):e0233501.სრული ტექსტი აბსტრაქტი
167. Chang CJ, Chan YL, Pramukti I, et al. People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis. Arch Osteoporos. 2021 Feb 27;16(1):47. აბსტრაქტი
168. Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009 Jan 2;23(1):41-50.სრული ტექსტი აბსტრაქტი
169. Yanik EL, Napravnik S, Cole SR, et al. Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis. 2013 Sep;57(5):756-64.სრული ტექსტი აბსტრაქტი
170. Silverberg MJ, Chao C, Leyden WA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9.სრული ტექსტი აბსტრაქტი
171. Silverberg MJ, Lau B, Achenbach CJ, et al. Cumulative incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern Med. 2015 Oct 6;163(7):507-18.სრული ტექსტი აბსტრაქტი
172. Morlat P, Roussillon C, Henard S, et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS. 2014 May 15;28(8):1181-91. აბსტრაქტი
173. Hessol NA, Whittemore H, Vittinghoff E, et al. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study. Lancet HIV. 2018 Nov;5(11):e647-55. აბსტრაქტი
174. Park LS, Tate JP, Sigel K, et al. Association of viral suppression with lower AIDS-defining and non-AIDS-defining cancer incidence in HIV-infected veterans: a prospective cohort study. Ann Intern Med. 2018 Jul 17;169(2):87-96. აბსტრაქტი
175. Klein MB, Althoff KN, Jing Y, et al. Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras. Clin Infect Dis. 2016;63:1160-7.სრული ტექსტი აბსტრაქტი
176. Chan P, Brew BJ. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Curr HIV/AIDS Rep. 2014 Sep;11(3):317-24. აბსტრაქტი
177. Wang Y, Liu M, Lu Q, et al. Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis. Neurology. 2020 Nov 10;95(19):e2610-21. აბსტრაქტი
178. Eshun-Wilson I, Siegfried N, Akena DH, et al. Antidepressants for depression in adults with HIV infection. Cochrane Database Syst Rev. 2018 Jan 22;(1):CD008525.სრული ტექსტი აბსტრაქტი
179. Monroe AK, Glesby MJ, Brown TT, et al. Diagnosing and managing diabetes in HIV-infected patients: current concepts. Clin Infect Dis. 2015 Feb 1;60(3):453-62.სრული ტექსტი აბსტრაქტი
180. Nansseu JR, Bigna JJ, Kaze AD, et al. Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Epidemiology. 2018 May;29(3):431-41.სრული ტექსტი აბსტრაქტი
181. Nduka CU, Stranges S, Kimani PK, et al. Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV-infected patients? A meta-analysis. Diabetes Metab Res Rev. 2017 Sep;33(6). აბსტრაქტი
182. Bhatia R, Murphy AB, Raper JL, et al. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems. AIDS. 2015 Jan 2;29(1):77-81.სრული ტექსტი აბსტრაქტი
183. Crothers K, Morris A. HIV infection and lung function decline: challenges, clinical implications, and new questions. AIDS. 2013 May 15;27(8):1345-7. აბსტრაქტი
184. Ensink RJH, Kuper H. Is hearing impairment associated with HIV? A systematic review of data from low- and middle-income countries. Trop Med Int Health. 2017 Dec;22(12):1493-504. აბსტრაქტი
185. Chokuda E, Reynolds C, Das S. Association of low vitamin D with complications of HIV and AIDS: a literature review. Infect Disord Drug Targets. 2020;20(2):122-42. აბსტრაქტი
186. Brooks JT, Kawwass JF, Smith DK, et al. Effects of antiretroviral therapy to prevent HIV transmission to women in couples attempting conception when the man has HIV infection - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017 Aug 18;66(32):859-60.სრული ტექსტი აბსტრაქტი
187. Kawwass JF, Smith DK, Kissin DM, et al. Strategies for preventing HIV infection among HIV-uninfected women attempting conception with HIV-infected men - United States. MMWR Morb Mortal Wkly Rep. 2017 Jun 2;66(21):554-7.სრული ტექსტი აბსტრაქტი
188. National Institute for Health and Care Excellence. HIV testing: increasing uptake among people who may have undiagnosed HIV. Dec 2016 [internet publication].სრული ტექსტი
189. Fowler MG, Newell ML. Breast-feeding and HIV-1 transmission in resource-limited settings. J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):230-9. აბსტრაქტი
ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას